Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis

Chimeric Antigen Receptor (CAR) T-cell therapy is a promising treatment option for patients suffering from B-cell- and plasma cell-derived hematologic malignancies and is being adapted for the treatment of solid cancers. However, CAR T is associated with frequently severe toxicities such as cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhardt, Bryanna, Lee, Patrick, Sasine, Joshua P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954220/
https://www.ncbi.nlm.nih.gov/pubmed/36831198
http://dx.doi.org/10.3390/cells12040531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954220/
https://www.ncbi.nlm.nih.gov/pubmed/36831198
http://dx.doi.org/10.3390/cells12040531

Ejemplares similares